On Friday, Macrogenics Inc (NASDAQ: MGNX) was -4.43% drop from the session before settling in for the closing price of $1.58. A 52-week range for MGNX has been $0.99 – $5.77.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 45.47% over the last five years. When this article was written, the company’s average yearly earnings per share was at -87.85%. With a float of $58.00 million, this company’s outstanding shares have now reached $63.09 million.
The firm has a total of 341 workers. Let’s measure their productivity. In terms of profitability, gross margin is 83.48%, operating margin of -65.25%, and the pretax margin is -36.0%.
Macrogenics Inc (MGNX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Macrogenics Inc stocks. The insider ownership of Macrogenics Inc is 8.07%, while institutional ownership is 80.17%. The most recent insider transaction that took place on Feb 15 ’25, was worth 1,083. In this transaction VP, Controller & Treasurer of this company sold 423 shares at a rate of $2.56, taking the stock ownership to the 9,532 shares.
Macrogenics Inc (MGNX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -87.85% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -23.54% during the next five years compared to 19.47% growth over the previous five years of trading.
Macrogenics Inc (NASDAQ: MGNX) Trading Performance Indicators
You can see what Macrogenics Inc (MGNX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.11. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.89, a number that is poised to hit -0.61 in the next quarter and is forecasted to reach -1.76 in one year’s time.
Technical Analysis of Macrogenics Inc (MGNX)
Analysing the last 5-days average volume posted by the [Macrogenics Inc, MGNX], we can find that recorded value of 0.29 million was lower than the volume posted last year of 0.68 million. As of the previous 9 days, the stock’s Stochastic %D was 45.29%. Additionally, its Average True Range was 0.13.
During the past 100 days, Macrogenics Inc’s (MGNX) raw stochastic average was set at 19.92%, which indicates a significant decrease from 40.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 84.44% in the past 14 days, which was higher than the 83.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5462, while its 200-day Moving Average is $2.8557. Now, the first resistance to watch is $1.5600. This is followed by the second major resistance level at $1.6100. The third major resistance level sits at $1.6500. If the price goes on to break the first support level at $1.4700, it is likely to go to the next support level at $1.4300. Now, if the price goes above the second support level, the third support stands at $1.3800.
Macrogenics Inc (NASDAQ: MGNX) Key Stats
There are 63,090K outstanding shares of the company, which has a market capitalization of 95.27 million. As of now, sales total 149,960 K while income totals -66,970 K. Its latest quarter income was 13,190 K while its last quarter net income were -41,040 K.
